Why monitor glucose in critically ill patients?

Clinical studies have shown improved morbidity and mortality when glucose is controlled to < 180 mg/dL (10 mmol/L), as well when preventing hypoglycemic events or excessive glucose variability. However, studies have also shown that good glycemic control is difficult to achieve. It is posited that this difficulty could be related to inaccuracy of readings, uncalibrated instruments, lack of trending data, etc. The OptiScannerĀ® 5000 is designed to automatically measure glucose and deliver trending information without the burden of calibration or additional resources to help clinicians achieve the right glucose control.